Anzeige
Mehr »
Samstag, 07.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QFCN | ISIN: US09075X1081 | Ticker-Symbol:
NASDAQ
06.06.25 | 22:00
0,303 US-Dollar
+7,49 % +0,021
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
BIODESIX INC Chart 1 Jahr
5-Tage-Chart
BIODESIX INC 5-Tage-Chart

Aktuelle News zur BIODESIX Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiBiodesix auf der 45. jährlichen William Blair Growth Stock Konferenz: Fokus auf Lungengesundheit3
30.05.BIODESIX INC - S-8, Securities to be offered to employees in employee benefit plans1
22.05.Biodesix, Inc.: Biodesix Announces New Data on the VeriStrat Test to be Presented at the 2025 ASCO Annual Meeting1
BIODESIX Aktie jetzt für 0€ handeln
21.05.BIODESIX INC - 8-K, Current Report1
21.05.Scotiabank cuts Biodesix stock target to $2, maintains outlook2
15.05.Biodesix, Inc.: Biodesix Announces New Clinical and Economic Data for its Nodify Lung Tests at ISPOR and ATS106LOUISVILLE, Colo., May 15, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, announced that new data will be presented at the International Society for...
► Artikel lesen
15.05.Biodesix Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)1
14.05.Biodesix, Inc.: Denver Post Names Biodesix a Winner of Top Workplaces 2025 Award1
14.05.Biodesix Analysts Lower Their Forecasts After Downbeat Q1 Results1
14.05.Biodesix GAAP EPS of -$0.08 misses by $0.02, revenue of $18M misses by $3.23M3
14.05.Biodesix stock rating cut to Market Perform at William Blair5
14.05.Canaccord cuts Biodesix stock target to $1.50, keeps buy rating1
14.05.Biodesix revises 2025 revenue guidance to $80M-$85M amid sales force reconfiguration and primary care expansion1
13.05.BIODESIX INC - 10-Q, Quarterly Report2
13.05.Biodesix, Inc.: Biodesix Announces First Quarter 2025 Results and Highlights114Total Q1 2025 Revenue of $18.0 million, an increase of 21% over Q1 2024; Gross margins of 79.4% for Q1 2025; Q1 2025 Net loss improved by 18% compared to Q1 2024; Updated 2025 Revenue Guidance to...
► Artikel lesen
29.04.Biodesix, Inc.: Biodesix to Report First Quarter 2025 Financial Results on May 13, 20251
23.04.Biodesix, Inc.: Biodesix partner, Friends of Cancer Research, publishes data in Clinical Cancer Research, demonstrating strong association between ctDNA changes and treatment outcomes for patients with solid tumor types3
17.04.BIODESIX INC - 8-K, Current Report1
04.03.Biodesix, Inc. (BDSX): Among Penny Stocks with Insider Buying in 20251
03.03.Biodesix, Inc. Q4 Loss Declines1
Weiter >>
32 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1